Overview
Allergic colitis, also known as allergic proctocolitis, is a condition primarily affecting infants, characterized by inflammation of the colonic mucosa triggered by food allergens, most commonly cow's milk protein. This condition typically manifests in the first few months of life with rectal bleeding, often without significant systemic symptoms. The pathophysiology involves immune responses mediated by CD8 lymphocytes, TH-2 type lymphocytes, and eosinophils, leading to mucosal inflammation and characteristic histopathological findings. Understanding the role of gut microbiota, particularly the reduced levels of bifidobacteria and increased clostridia, provides insights into potential diagnostic markers and therapeutic targets. This guideline aims to provide clinicians with a comprehensive overview of the epidemiology, clinical presentation, diagnosis, differential diagnosis, management, prognosis, and considerations for special populations affected by allergic colitis.
Pathophysiology
The pathophysiology of allergic colitis involves a complex interplay of immune mechanisms centered around the gastrointestinal tract. Activated CD8 lymphocytes and TH-2 type lymphocytes play pivotal roles in orchestrating the inflammatory response, characterized by the infiltration of eosinophils into all layers of the colonic mucosa [PMID:23843067]. This eosinophilic infiltration, often observed at levels of 5-15 eosinophils per high-power field in histopathologic examinations, underscores the allergic nature of the inflammation [PMID:23445743]. Additionally, circulating memory cells contribute to the persistent immune response, while the secretion of TNF-α by activated lymphocytes amplifies the inflammatory cascade. Studies comparing fecal microbiota between healthy exclusively breast-fed infants and those with allergic colitis reveal significant alterations, specifically lower levels of beneficial bifidobacteria and higher levels of potentially pathogenic clostridia [PMID:18661304]. These microbial shifts suggest that gut dysbiosis may play a role in the development and persistence of allergic colitis, offering potential avenues for both diagnosis and intervention through probiotic supplementation aimed at restoring a healthier microbial balance.
Epidemiology
Allergic colitis predominantly affects infants, with an estimated prevalence of food allergies ranging from 2.5% to 5% in the pediatric population [PMID:23843067]. Cow's milk allergy is a significant contributor, implicated in approximately 50% of cases [PMID:23843067]. There is a notable familial trend, with a higher incidence observed in infants with a family history of atopy, indicating a genetic predisposition. Specific studies highlight the condition's occurrence in diverse infant populations, such as a report detailing five infants diagnosed with allergic colitis linked to cow's milk protein exposure, emphasizing its clinical relevance [PMID:23445743]. These epidemiological insights underscore the importance of considering allergic colitis in the differential diagnosis of gastrointestinal symptoms in infants, particularly those with a history of atopic conditions or exposure to common allergens like cow's milk.
Clinical Presentation
Infants with allergic colitis typically present with rectal bleeding, often between 20 and 90 days of life, without significant systemic symptoms such as dehydration, fever, or signs of toxemia [PMID:23843067]. The bleeding is usually mild and intermittent, reflecting the localized nature of the inflammation. However, clinical presentations can vary, as evidenced by a case report illustrating atypical features such as pneumatosis intestinalis on abdominal X-rays, which can complicate differentiation from necrotizing enterocolitis [PMID:29210890]. Beyond rectal bleeding, infants may exhibit other gastrointestinal symptoms consistent with acute inflammation, including irritability and feeding difficulties. Laboratory findings can include iron deficiency anemia, likely due to chronic, albeit mild, blood loss, and peripheral eosinophilia, although not all patients show this latter marker [PMID:23840121]. Notably, skin prick tests often yield positive results for milk protein, yet these do not always correlate with specific IgE levels, highlighting the complexity in interpreting allergic markers [PMID:23445743]. These varied presentations underscore the need for a thorough clinical evaluation and consideration of dietary triggers in diagnosis.
Diagnosis
Diagnosing allergic colitis involves a multi-faceted approach, integrating clinical history, exclusion of other causes, and specific diagnostic criteria. Key diagnostic criteria include the presence of rectal bleeding in adequately nourished infants, exclusion of infectious colitis through appropriate testing (e.g., stool cultures, viral panels), and resolution of symptoms following the elimination of cow's milk and dairy products from the diet [PMID:23843067]. Colonoscopic examinations frequently reveal mucosal abnormalities such as lymphonodular hyperplasia or aphthous ulcerations, observed in 83% of infants with allergic colitis [PMID:23840121]. Histopathologic examination of biopsy specimens typically shows acute inflammation with characteristic eosinophilic infiltration in the lamina propria, a hallmark feature of this condition [PMID:23445743]. Additionally, laboratory findings may include elevated levels of IgE antibodies specific to milk proteins, alongside lower levels of protective immunoglobulins like IgG4 and IgA [PMID:23445743]. The fecal microbiota profile, characterized by reduced bifidobacteria and increased clostridia, offers a novel diagnostic approach, potentially aiding in distinguishing allergic colitis from other gastrointestinal disorders [PMID:18661304]. These diagnostic tools collectively help clinicians confidently identify allergic colitis and differentiate it from other inflammatory conditions affecting the colon.
Differential Diagnosis
Distinguishing allergic colitis from other gastrointestinal conditions, particularly necrotizing enterocolitis (NEC), can be challenging due to overlapping clinical and radiological features. Both conditions may present with rectal bleeding and pneumatosis intestinalis on abdominal imaging, complicating early diagnosis [PMID:29210890]. NEC typically affects premature infants and is characterized by more severe systemic symptoms such as sepsis, metabolic acidosis, and abdominal distension, which are less common in allergic colitis. Histopathological examination remains crucial in differentiating these conditions, as NEC involves necrosis and ulceration of the bowel wall, contrasting with the eosinophilic infiltration seen in allergic colitis [PMID:23445743]. Other differential diagnoses include infectious colitis, inflammatory bowel disease (IBD), and cow's milk protein-induced enteropathy, each requiring specific exclusion criteria and diagnostic evaluations to rule out. Clinicians must maintain a high index of suspicion and employ a comprehensive diagnostic approach to accurately identify allergic colitis and avoid misdiagnosis.
Management
The cornerstone of managing allergic colitis involves dietary modifications aimed at eliminating the offending allergen, primarily cow's milk protein. Switching to a hypoallergenic formula, such as an extensively hydrolyzed formula or an amino acid-based formula, often leads to rapid symptom resolution, with rectal bleeding typically disappearing within 48 to 72 hours [PMID:23843067]. Infants on L-amino acid-based formulas experience a shorter duration of symptoms compared to those continuing breastfeeding, highlighting the efficacy of these specialized formulas [PMID:23840121]. For breastfed infants, maternal elimination diets removing cow's milk protein can also be effective, although symptom resolution may take longer [PMID:23840121]. Beyond dietary interventions, monitoring for nutritional deficiencies, particularly iron deficiency, is crucial given the association with chronic, albeit mild, blood loss [PMID:23840121]. Probiotic interventions, targeting the restoration of beneficial gut microbiota like bifidobacteria, represent an emerging area of interest in managing allergic colitis, potentially enhancing the gut barrier function and modulating immune responses [PMID:18661304]. Regular follow-up is essential to ensure sustained symptom resolution and to monitor for any recurrence or development of new symptoms, ensuring comprehensive care and timely adjustments to the management plan.
Prognosis & Follow-up
The prognosis for infants diagnosed with allergic colitis is generally favorable, with most patients experiencing complete resolution of symptoms following appropriate dietary interventions. Long-term follow-up studies indicate that rectal bleeding typically resolves within weeks to months, with no recurrence observed at follow-up visits, such as the 3-month mark [PMID:23840121]. This positive outcome supports the effectiveness of early and accurate diagnosis and management strategies. However, ongoing monitoring is advised to address any lingering nutritional deficiencies or to reassess dietary needs as the infant grows. Regular clinical assessments and, when necessary, repeat laboratory evaluations help ensure sustained health and development, minimizing the risk of long-term complications.
Special Populations
Special considerations arise when managing allergic colitis in infants who continue to be breastfed despite the condition. While breastfed infants may experience a longer duration of symptoms compared to those on hypoallergenic formulas, all patients in follow-up studies showed resolution of symptoms by three months, suggesting that breastfeeding should not be discouraged [PMID:23840121]. Maternal dietary modifications, particularly the elimination of cow's milk protein, can be effective in managing symptoms in breastfed infants. Additionally, infants with complex medical histories or those at higher risk due to prematurity or underlying conditions require tailored management plans that balance nutritional needs with allergen avoidance. Clinicians must remain vigilant, adapting strategies to individual patient needs while ensuring adequate nutrition and monitoring for any signs of delayed recovery or complications.
References
1 Fagundes-Neto U, Ganc AJ. Allergic proctocolitis: the clinical evolution of a transitory disease with a familial trend. Case reports. Einstein (Sao Paulo, Brazil) 2013. link 2 Molnár K, Pintér P, Győrffy H, Cseh A, Müller KE, Arató A et al.. Characteristics of allergic colitis in breast-fed infants in the absence of cow's milk allergy. World journal of gastroenterology 2013. link 3 Liu H, Turner TWS. Allergic Colitis With Pneumatosis Intestinalis in an Infant. Pediatric emergency care 2018. link 4 Yu MC, Tsai CL, Yang YJ, Yang SS, Wang LH, Lee CT et al.. Allergic colitis in infants related to cow's milk: clinical characteristics, pathologic changes, and immunologic findings. Pediatrics and neonatology 2013. link 5 Smehilová M, Vlková E, Nevoral J, Flajsmanová K, Killer J, Rada V. Comparison of intestinal microflora in healthy infants and infants with allergic colitis. Folia microbiologica 2008. link